Nanoparticle-enabled blood test for pancreatic cancer detection
Project Objectives
Implementation of a test based on the use of nanoparticles aimed at identifying patients with pancreatic adenocarcinoma Development and patent of an integrated platform for pancreatic cancer early diagnosis.
Start and end date
02/01/2018 - 01/01/2023
Project Manager
Prof. Roberto Coppola, Dr. Damiano Caputo (Patients enrollment, analysis and interpretation of the obtained results)
Coordinating institution of the project
Sapienza University of Rome
Other Institutions involved
Harvard Medical School
Catholic University of Sacred Heart of Rome